Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
13.81
-0.87 (-5.96%)
Sep 15, 2025, 4:00 PM EDT - Market closed
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $971.87 million as of September 15, 2025. Its market cap has increased by 89.71% in one year.
Market Cap
971.87M
Enterprise Value
974.20M
1-Year Change
89.71%
Ranking
Category
Stock Price
$13.81
Market Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $971.87M, an increase of 654.24%. That is a compound annual growth rate of 8.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 979.59M | 50.79% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | 992.79M | -10.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |